Speaking to Shephard at AUSA 2024, Dr. Gozali said: “We expect the system to be ready for launch in fiscal year 2025.” Gozali ...

UVision USA is to unveil an autonomous multi-launch system built around its Hero-120 loitering munition at AUSA 2024 in ...

The acquisition supports the commercial expansion of the Luminelle system, said CEO Allison London Brown, who cofounded ...

UVisionUSA, a global pioneer in loitering munition systems, unveils its latest innovation: the autonomous multi-launch system ...

The new UVision loitering munition multilauncher made its conference floor debut as the company prepares to send the system to Project Convergence Capstone 5 early ...

The acquisition enables Caldera Medical to provide solutions to treat gynaecological conditions such as polyps and fibroids.

Uvision, an Israeli competitor, has racked up sales of its Hero loitering munitions to U.S. special forces and foreign militaries. But the Marines quietly canceled a contract UVision won in 2021 ...

Caldera Medical Acquires UVision360 and the LUMINELLE Product Family, Expanding Minimally Invasive Hysteroscopy Portfolio ...

Other sales of loitering munitions have come out of the Middle East. In December, Israel signed a deal to sell Uvision Hero-120 and Hero-30 loitering munitions to Argentina. Turkey, which has had ...

The second day of the Association of the United States Army meeting featured exhibits by defense industries from around the ...

Caldera Medical, a leader in women's health medical devices, announced today the acquisition of UVision 360, Inc., the developer of the LUMINELLE® hysteroscopy and cystoscopy systems. This ...